As sweeping societal changes occur worldwide, the trend of having animals as companions is on the rise. Many lonely aged people, nuclear families, and single persons are choosing to have an animal in their household. Estimates show that in the United States alone, about 62% of all households have a pet. Pet ownership numbers are also rising in other countries worldwide.
However, animals are also the carriers of various diseases and infections that could be contracted by humans around them. Likewise, companion animals also stand the risk of contracting infections or diseases from humans around them. Vaccination is thus an important aspect that pet owners are urged not to neglect – for the safety of both the pets and owners alike.
Avail a Sample of Research Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=11390
The companion animal vaccines market has seen an uptick in revenues in keeping with the growing popularity of keeping pets at home. Regular planned vaccinations are now regarded as being integral to the entire pet rearing and maintenance process. Consequently, the formulation of newer varieties of companion animal vaccines is helping this progress. Companion animal vaccines are administered not just to pets such as dogs, cats, pet reptiles, and the like, but also to livestock.
TMR projects a positive outlook for the global companion animal vaccines market in the near future. The market is expected to grow on account of the burgeoning number of pet owners in developing regions as well. The report is a comprehensive compilation of the emergent trends that are projected to palpably impact the future of this market and how companies are responding to this change.
Concerns associated with the rising prevalence of zoonotic diseases and the discovery of new diseases among animals are providing a push to the companion animal vaccines market. Besides this high-impact driver, the market is also gaining from the growing focus on implementing animal welfare initiatives and governments laying more emphasis on keeping animal-related diseases in check.
However, developing animal vaccines is a rather lengthy and expensive process – the impact of which can be seen in the form of the high prices that these vaccines command. That puts them beyond the reach of some consumer classes, especially if suitable reimbursement schemes are not available to them. The other factor that is negatively impacting the companion animal vaccines market for livestock is the growing number of vegetarians in the world who may consume dairy products but not meat.
The report classifies the global companion animal vaccines market basis the following criteria: diseases, product, and technology. Based on product type, the market is segmented into feline, canine, bovine, and others. Likewise, the diseases for which companion animal vaccines are available include: Rabies, hepatitis, leukemia, and others.
By technology used for the development and formulation of the vaccine, the global companion animal vaccines market has been segmented thus: DNA, recombinant, inactivated, toxoid, conjugate, and other vaccines. Considerable research is being undertaken to formulate more effective vaccines with lower price tags.
The global market for companion animal vaccines has been segmented as follows: Asia Pacific, North America, Europe, and Rest of the World. TMR projects the market to fare well in North America and Europe, where pet ownership numbers as well as meat consumption have been traditionally high. Europe currently accounts for a sizeable share in the global companion animal vaccines market.
In Latin American and Asian countries, a new class of affluent consumers is emerging. These consumers are keener on having a companion animal in their household and will thus fuel the global market for companion animal vaccines. The vast population here and the untapped opportunities mean that market players have considerable gains to make by targeting these regions.
Top players in the global companion animals market are: Merial Inc. (Sanofi), Bayer Healthcare, Boehringer Ingelheim (Germany), Novartis Animal Health Inc., and Merck Animal Health (U.S).
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.